CIK 0001754068 · Non-accelerated filer<br>Smaller reporting company
Kalaris Therapeutics, Inc.
Sign in to watch- Ticker
- KLRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831971007
- Phone
- 650-249-2727
- Business address
- 400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
- Former names
- Allovir, Inc., ViraCyte, Inc.
- 4 Insider Changes in Ownership
- 8-K Event Shareholder vote results
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Insider Changes in Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 8-K Event Executive or director change
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- S-3 Offering Registration Statement
Page 2 of 36 · 701 filings